Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.220
+0.020 (1.67%)
At close: Feb 27, 2026, 4:00 PM EST
1.142
-0.078 (-6.36%)
After-hours: Feb 27, 2026, 6:04 PM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $51.28 million as of February 27, 2026. Its market cap has increased by 25.44% in one year.
Market Cap
51.28M
Enterprise Value
49.66M
1-Year Change
25.44%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $51.28M, an increase of 2,784.89%. That is a compound annual growth rate of 171.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 51.28M | -12.96% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 54.03M |
| Nutriband | 53.97M |
| LeonaBio | 53.68M |
| BeyondSpring | 53.46M |
| MindWalk Holdings | 52.53M |
| Plus Therapeutics | 52.33M |
| OS Therapies | 51.06M |
| MiNK Therapeutics | 50.79M |